Your browser doesn't support javascript.
loading
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis.
Hughes, Dyfrig A; Culeddu, Giovanna; Plumpton, Catrin O; Wood, Eifiona; Dick, Andrew D; Jones, Ashley P; McKay, Andrew; Williamson, Paula R; Compeyrot Lacassagne, Sandrine; Hardwick, Ben; Hickey, Helen; Woo, Patricia; Beresford, Michael W; Ramanan, Athimalaipet V.
Afiliación
  • Hughes DA; Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, United Kingdom. Electronic address: d.a.hughes@bangor.ac.uk.
  • Culeddu G; Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, United Kingdom.
  • Plumpton CO; Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, United Kingdom.
  • Wood E; Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, United Kingdom.
  • Dick AD; Bristol Eye Hospital, Bristol, United Kingdom; Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Jones AP; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • McKay A; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Williamson PR; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Compeyrot Lacassagne S; UCL Institute of Ophthalmology and National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom.
  • Hardwick B; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Hickey H; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Woo P; UCL Institute of Ophthalmology and National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, United Kingdom.
  • Beresford MW; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.
  • Ramanan AV; Bristol Medical School, University of Bristol, Bristol, United Kingdom; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Ophthalmology ; 126(3): 415-424, 2019 03.
Article en En | MEDLINE | ID: mdl-30336181
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Juvenil / Uveítis / Metotrexato / Análisis Costo-Beneficio / Antirreumáticos / Adalimumab Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Ophthalmology Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Juvenil / Uveítis / Metotrexato / Análisis Costo-Beneficio / Antirreumáticos / Adalimumab Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Ophthalmology Año: 2019 Tipo del documento: Article